Diaxonhit ditches Alzheimer’s test
This article was originally published in Clinica
Executive Summary
French biotech firm Diaxonhit is to discontinue its AclarusDx Alzheimer’s diagnostic line in 2014 and concentrate, instead, on its more profitable businesses.